Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven's Terms and Policy

Already have an account? Login here

JIM CRAMER INVESTING PERSONAL FINANCE RETIREMENT TECHNOLOGY MARKETS HOW-TO VIDEO FINANCIAL ADVISOR CENTER

Pharmaceuticals

Novavax CEO: Avian Flu Results Very Positive for Vaccine Maker

5 Stock Gainers for Wednesday: Novavax, Fiverr, Overstock.com

By Rob Lenihan

Novavax Lead

Novavax Jumps on Solid Covid-19 Vaccine Candidate Results

Novavax Lead

Novavax Surges on Promising Covid-19 Vaccine Trial Results

By M. Corey Goldman

Eli Lilly Phase 3 Pancreatic Cancer Study Fails to Meet Primary Endpoint

Eli Lilly Begins Phase III Trial of Antibody Against Covid-19

By Rob Daniel

Disney Lead

Disney, Take-Two Among Top Earnings Reports Due

By Tom Bemis

Coronavirus: Chinese Pharmaceutical Firm Says Covid-19 Vaccine May Be Ready This Year

Sanofi and Glaxo Get 'Operation Warp Speed' Covid-19 Funding

Gilead Lead

Gilead Remdesivir Output Outlook Draws Analyst’s Skepticism

By Dan Weil

Jim Cramer on the Stock Market: Thoughts on Merck's Deal for Cubist

Merck Pulls Off a Banner Quarter and Says There's More to Come

AbbVie Lead

AbbVie Shares Climb After Adjusted Profit Beats Analyst Views

By Tony Owusu

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

Sanofi and GlaxoSmithKline Get $2.1 Billion to Develop Covid-19 Vaccine

By M. Corey Goldman

Merck Second-Quarter Results Beat Forecasts

Merck Posts Second-Quarter Earnings Beat and Lifts Guidance

By M. Corey Goldman

Eastman Kodak Co.

Kodak Shares Leap for Second Day on Loan, Ingredients Deal

By Dan Weil

Kodak: From Blue Chip to Bankrupt

Kodak Awarded Government Loan for Drug Production, Stock Up 500%

Busted Stocks: Eastman Kodak

Kodak Gets $765M Government Loan for Generic Drugs Production

By Dan Weil

Spectrum Pharma Implodes On Colossal Fusilev Sales Warning

Spectrum Pharma Spikes on Positive Lung Cancer Treatment Data

By Tony Owusu

Don't Buy Biogen

Biogen Gets Double Upgrade at Morgan Stanley

By Tony Owusu

The Walgreens and Rite Aid Merger May Finally Receive FTC Approval

Walgreens CEO Steps Down After 5 Years

Moderna Lead

Moderna Vaccine Effort Now Armed With Nearly a Billion Dollars in Fed Funds

By Adam Smith

Merck Wins Drug Approval and Part of a Court Case; Here's How to Trade the Stock

Drug Stocks Fall on Trump's Price Control Orders

By Dan Weil

Kite Gilead Lead

Kite CEO on First CAR T Treatment Approval by FDA

Wall Street Lead

5 Stock Gainers for Wednesday: BioNTech, VBI Vaccines, Calix

By Rob Lenihan

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Profit Up on Demand for Virus-Testing Products

By Rob Lenihan

Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet

Acadia Depression Drug Misses Key Endpoint in Phase III Trial

By Dan Weil

Moleculin Biotech gets good verbal Ok from FDA which should cut time to Phase 1/2 trial down

Moleculin Shares Jump on Progress With Virus-Drug Candidate

By Rob Lenihan

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2020 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.